Showing 1 - 3 results of 3 for search 'Hanni K Uusi-Kerttula', query time: 0.03s Refine Results
  1. 1
    Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5<sub>NULL</sub>-A20

    Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5<sub>NULL</sub>-A20 by James A. Davies, Gareth Marlow, Hanni K. Uusi-Kerttula, Gillian Seaton, Luke Piggott, Luned M. Badder, Richard W. E. Clarkson, John D. Chester, Alan L. Parker

    Published 2021-05-01
    Get full text
    Article
  2. 2
    897-C TROCEPT tumor-specific targeting and replication enables in-tumor production of immune checkpoint inhibitors following intravenous delivery

    897-C TROCEPT tumor-specific targeting and replication enables in-tumor production of immune checkpoint inhibitors following intravenous delivery by Andrew B Gerry, Bent K Jakobsen, David Krige, Rahul C Khanolkar, James A Davies, Alexander T Baker, Thomas A Webb, Alicia Teijeira-Crespo, Hanni K Uusi-Kerttula, Lucy M Williams, Samantha L Moore, Johanne M Pentier, Alan L Parker, David K Cole

    Published 2023-11-01
    Article
  3. 3
    Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10

    Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10 by Emily A. Bates, James A. Davies, Jana Váňová, Davor Nestić, Valerie S. Meniel, Sarah Koushyar, Tabitha G. Cunliffe, Rosie M. Mundy, Elise Moses, Hanni K. Uusi-Kerttula, Alexander T. Baker, David K. Cole, Dragomira Majhen, Pierre J. Rizkallah, Toby Phesse, John D. Chester, Alan L. Parker

    Published 2022-06-01
    Get full text
    Article

Search Tools: